What is MapLight Therapeutics, Inc. Common Stock's Market Cap?

MapLight Therapeutics, Inc. Common Stock's Market Cap is $369.6M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Enterprise Value?

MapLight Therapeutics, Inc. Common Stock's Enterprise Value is $64.9M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's EV / EBITDA?

MapLight Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Net Income (TTM)?

MapLight Therapeutics, Inc. Common Stock's Net Income (TTM) is -$229.8M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's EBITDA?

MapLight Therapeutics, Inc. Common Stock's EBITDA is -$242.3M, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.96, based on as-reported figures from SEC (XBRL) filings.

What is MapLight Therapeutics, Inc. Common Stock's Net Debt?

MapLight Therapeutics, Inc. Common Stock's Net Debt is -$304.7M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

MapLight Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01JZ5DBS8

7.97▼ 0.28 (-3.39%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 8.25
Day's Range: 7.84 – 8.29
52-Week Range: 7.46 – 40.43
Volume: 305.3K
Avg Volume: 434.2K

Share Statistics

Shares Outstanding
Employees: 133
Exchange: XNAS
Listed: 2025-10-27

Share count as of August 7, 2026

MapLight Therapeutics, Inc. Common Stock (MPLT) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about MapLight Therapeutics, Inc. Common Stock (MPLT)

What is MapLight Therapeutics, Inc. Common Stock's Market Cap?: MapLight Therapeutics, Inc. Common Stock's Market Cap is $369.6M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Enterprise Value?: MapLight Therapeutics, Inc. Common Stock's Enterprise Value is $64.9M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's EV / EBITDA?: MapLight Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Net Income (TTM)?: MapLight Therapeutics, Inc. Common Stock's Net Income (TTM) is -$229.8M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's EBITDA?: MapLight Therapeutics, Inc. Common Stock's EBITDA is -$242.3M, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: MapLight Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.96, based on as-reported figures from SEC (XBRL) filings.
What is MapLight Therapeutics, Inc. Common Stock's Net Debt?: MapLight Therapeutics, Inc. Common Stock's Net Debt is -$304.7M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · MPLTAs-filed SEC (XBRL) data